PEDEVCO CORP. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by PEDEVCO CORP. on August 28, 2025. The report details corporate governance actions taken on this date, specifically the results of the 2025 Annual Meeting of Stockholders and the granting of restricted stock awards to non-employee directors.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on equity compensation and shareholder voting results.
Material Changes and Corporate Actions
- Restricted Stock Awards: On August 28, 2025, the Company granted a total of 540,000 shares of restricted common stock under the 2021 Equity Incentive Plan to three non-employee directors:
- Mr. John Scelfo: 200,000 shares (vesting July 12, 2026).
- Dr. Simon G. Kukes (Chairman): 200,000 shares (vesting January 1, 2026).
- Mr. H. Douglas Evans: 140,000 shares (vesting September 27, 2026).
- Annual Meeting Results:
- Quorum: 68,670,136 shares were present, representing a majority of the 91,829,352 shares entitled to vote as of the June 30, 2025 record date.
- Director Elections: All five nominees (John J. Scelfo, Dr. Simon G. Kukes, H. Douglas Evans, J. Douglas Schick, and John K. Howie) were elected by a plurality of votes cast. No solicitation in opposition occurred.
- Auditor Ratification: Stockholders approved the appointment of Weaver and Tidwell, L.L.P., as the independent registered public accounting firm for the 2025 fiscal year.
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, or discussion of risks and contingencies. The restricted stock awards are subject to the recipient remaining a Board member on the vesting date and include a 100% vesting acceleration clause in the event of a Change of Control.
Investor Verification Checklist
- Verify the total number of outstanding shares (91,829,352 as of June 30, 2025) to assess the dilution impact of the 540,000 new restricted shares.
- Review the Definitive Proxy Statement on Schedule 14A (filed July 11, 2025) for detailed biographies of the elected directors and the full text of the auditor ratification proposal.
- Confirm the specific vesting schedules and Change of Control definitions in the Restricted Shares Grant Agreement (incorporated by reference from Form S-8 filed September 1, 2021).
- Monitor future filings for the Company's 2025 financial results, as this 8-K does not contain performance metrics.